I think the complication was involved in the Japanese approval.The FDA approval was to be straight foward according to mention of this in various presentations I have read.What ever the hold up selling at the low $3.00s is short sighted to say the least.
If I was a seller I be looking over my shoulder for Murphys law
Regards,
- Forums
- ASX - By Stock
- new thread
I think the complication was involved in the Japanese...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)